Study to Determine the Accuracy of Prothrombin Time of Warfarinised blood.

Not Applicable

Completed

• Conditions: A prothrombin time test (PT) used to monitor patients taking the anticoagulant warfarin; Blood - Clotting disorders

• Registration Number: ACTRN12610000701022
• Lead Sponsor: niversal Biosensors Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients currently receiving warfarin treatment
Patients not receiving warfarin treatment

Exclusion Criteria

None

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
International Normalised Ratio(INR) values from the Universal Biosensors device will correlate with results obtained from the Roche CoaguChek and the laboratory reference method.[Results will be displayed immediately]

Secondary Outcome Measures

Name	Time	Method
International Normalised Ratio(INR) values from the Universal Biosensors device will correlate with results obtained from the Roche CoaguChek and the laboratory reference method over the extended range of haematocrits.[Results will be displayed immediately.]